×
About 2,108 results

ALLMedicine™ Androgenetic Alopecia Center

Research & Reviews  623 results

The efficacy of LED microneedle patch on hair growth in mice.
https://doi.org/10.1007/s00403-022-02476-3
Archives of Dermatological Research; Kittigul L, Meephansan J et. al.

Nov 24th, 2022 - Light penetration depth in the scalp is a key limitation of low-level light therapy for the treatment of androgenetic alopecia (AGA). A novel light emitting diode (LED) microneedle patch was designed to achieve greater efficacy by enhancing the pe...

The efficacy and safety of the combination of photobiomodulation therapy and pulsed ele...
https://doi.org/10.1111/jocd.15490
Journal of Cosmetic Dermatology; Choi MS, Park BC

Nov 9th, 2022 - Photobiomodulation therapy (PBMT) appears to be safe and effective for hair loss. Pulsed electromagnetic field therapy (PEMF) also has a positive biological effect on hair re-growth. We evaluated the efficacy and safety of both PBMT and PEMF for t...

The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter...
https://doi.org/10.1111/ijd.16454
International Journal of Dermatology; Kutlu Ö, Demircan YT et. al.

Oct 26th, 2022 - A broad spectrum of skin diseases, including hair and nails, can be directly or indirectly triggered by COVID-19. It is aimed to examine the type and frequency of hair and nail disorders after COVID-19 infection. This is a multicenter study conduc...

Use of autologous platelet-rich plasma in androgenetic alopecia in women: a systematic ...
https://doi.org/10.1080/09546634.2022.2138692
The Journal of Dermatological Treatment; de Oliveira AFQ, Arcanjo FPN et. al.

Oct 21st, 2022 - To conduct a systematic review and meta-analysis to verify the efficacy of using autologous platelet-rich plasma (PRP) in female pattern alopecia (FPA). Androgenetic alopecia is the leading cause of hair loss in men andwomen and often impacts self...

Digital health platforms expand access and improve care for male androgenetic alopecia.
https://doi.org/10.1111/ijd.16452
International Journal of Dermatology; Young PC, Mahajan C et. al.

Oct 18th, 2022 - Digital health solutions, specifically direct-to-consumer platforms, have been touted to make care accessible and convenient for patients. The aim of this article is to evaluate patients' reported reasons for choosing a platform for the treatment ...

see more →

Guidelines  2 results

Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss...
https://doi.org/10.1111/1346-8138.14470
The Journal of Dermatology; Manabe M, Tsuboi R et. al.

Jun 5th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...

Guidelines for management of androgenetic alopecia based on BASP classification--the As...
https://doi.org/10.1111/jdv.12034
Journal of the European Academy of Dermatology and Venere... Lee WS, Lee HJ et. al.

Nov 28th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...

see more →

Drugs  38 results see all →

Clinicaltrials.gov  108 results

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
https://clinicaltrials.gov/ct2/show/NCT05218642

Sep 27th, 2022 - KX-826 is a new investigational androgen receptor (AR) antagonist for the treatment of male pattern hair loss (androgenetic alopecia). A total of 120 subjects will be randomized to one of four cohorts: 2.5 mg BID, 5 mg QD, 5mg BID of KX-826 or pla...

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04011748

Sep 22nd, 2022 - Alopecia areata (AA) is a common autoimmune disease that results in loss of body hair in varying degrees. The condition is estimated to affect more than 6.5 million people in the United States alone (naaf.org), with a worldwide prevalence of 0.1% ...

A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)
https://clinicaltrials.gov/ct2/show/NCT05135468

Aug 10th, 2022 - A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Clinical Study ,the mean change from baseline in vertex target area hair count (TAHC) after treatment for 24 weeks.

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
https://clinicaltrials.gov/ct2/show/NCT04594018

Aug 5th, 2022 - The purpose of this study is to evaluate the efficacy of Finlândia hair lotion association in the treatment of androgenetic alopecia.

Thulium Laser and Topical Platelet Rich Plasma (PRP) vs. PRP Injection for the Treatment of Male Androgenetic Alopecia
https://clinicaltrials.gov/ct2/show/NCT05129254

Aug 5th, 2022 - This is a single institution, open-label, baseline-controlled, prospective study evaluating the use of a non-ablative fractionated thulium laser and topical autologous platelet-rich plasma (PRP) vs. PRP injection for the treatment of male androgen...

see more →

News  71 results

Low-dose oral minoxidil for the treatment of alopecia
https://www.mdedge.com/dermatology/article/257872/aesthetic-dermatology/low-dose-oral-minoxidil-treatment-alopecia
Lily Talakoub, MD

Sep 15th, 2022 - Therapeutic use of oral minoxidil in the treatment of androgenetic alopecia (AGA) is a lifeline for dermatologists who treat hair loss. Other than oral finasteride, vitamins, and topicals, there has been little advancement in the treatment of AGA.

Hormonal therapy a safe, long term option for older women with recalcitrant acne
https://www.mdedge.com/dermatology/article/257514/acne/hormonal-therapy-safe-long-term-option-older-women-recalcitrant-acne
Doug Brunk

Aug 31st, 2022 - PORTLAND, ORE. – During her dermatology residency training at the University of California, Irvine, Medical Center, Jenny Murase, MD, remembers hearing a colleague say that her most angry patients of the day were adult women with recalcitrant acne.

Low-Level Light Therapy Cap Shows Subtle Effects on Central Centrifugal Cicatricial Alopecia
https://www.medscape.com/viewarticle/979029

Aug 10th, 2022 - A low-level light therapy cap may be a safe, convenient treatment for some patients with central centrifugal cicatricial alopecia, though the treatment effects from a small prospective trial appear to be subtle. Central centrifugal cicatricial alo...

Fast Five Quiz: Hair Loss (Alopecia)
https://www.medscape.com/viewarticle/977806

Aug 1st, 2022 - Hair loss (alopecia) is a common health concern for both men and women. Androgenetic alopecia is a genetically determined disorder. Affected individuals usually have a typical patterned distribution of hair loss. Alopecia areata is a recurrent non...

Hair disorder treatments are evolving
https://www.mdedge.com/dermatology/article/255473/hair-nails/hair-disorder-treatments-are-evolving
Kathleen Doheny

Jun 15th, 2022 - “No matter who the patient is, whether a child, adolescent, or adult, the key to figuring out hair disease is getting a good history,” Maria Hordinsky, MD, professor and chair of the department of dermatology at the University of Minnesota, Minnea.

see more →

Patient Education  1 results see all →